Karyopharm Therapeutics
KPTI
#10853
Rank
โ‚น1.42 B
Marketcap
โ‚น62.80
Share price
-24.76%
Change (1 day)
-88.34%
Change (1 year)

Karyopharm Therapeutics (KPTI) Fails to deliver data

Key failure to deliver metrics for Karyopharm Therapeutics :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Karyopharm Therapeutics (KPTI) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Karyopharm Therapeutics (KPTI) - since 2025

Volume in USD (price x number of shares), data since 2025

Karyopharm Therapeutics (KPTI) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026โ‚น16.24 M58.05%
2025โ‚น10.27 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Abbott Laboratories
ABT
โ‚น9.78 Mโ‚น0.21 B๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น39.18 Mโ‚น0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น17.12 Mโ‚น92.07 M๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
โ‚น6.2 Mโ‚น30.62 M๐Ÿ‡บ๐Ÿ‡ธ USA